Probiotics: The Path to Better Digestive Health through Quality Clinical Trials
DuPont Nutrition & Health
Breaking News on Supplements & Nutrition - North AmericaEU edition
Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.
Spotlight
  AREDS2 data publishedLutein + zeaxanthin may reduce risk of progression to advanced AMD, compared to original AREDS formulaAdding lutein, zeaxanthin and/or omega-3 fatty acids to the AREDS eye health formula may not offer any... |
 AREDS2Lutein/zeaxanthin benefits for people with low dietary intakes is an ‘important message’ for the general population: OmniActive COOThe significant benefits of adding lutein and zeaxanthin to the AREDS formula for people with low dietary... |
 Website content an extension of labeling: FDA warning letter shows companies need to ‘think about their real estate space’The FDA has issued a warning letter for a company website that links to articles with disease... |
 Association to hold seminar on 'The Non-GMO Future'UNPA: ‘We sense that the GMO issue is substantially more significant than dietary supplement companies think’Dietary supplement manufacturers need to consider the implications of possible GMO labeling initiatives, with the issue more... |
 CSPI to Bayer: Fix your One A Day claims or we’ll start a lawsuitThe Center for Science in the Public Interest (CSPI) is threatening litigation against Bayer for alleged “deceptive practices... |
 Trade associations urge FDA to issue revised draft guidance on NDI ingredient identityThe five associations representing the dietary supplement industry have asked the Food and Drug Administration (FDA) to... |
 Vitamin Shoppe: 'Mytrition range doing well and we’ll expand it later this year'Vitamin Shoppe’s ‘unique’ multipacks for men and women branded as Mytrition are doing ‘very well’ and current... |
Not efficacy....
Efficacy is not a word in our industry. My opinion is all the regs hang on Identity, purity (strength)and safety. Efficacy is not a requirement, and the FDA just got spanked for requiring clinical trials for label claims. Efficacy is 21 CFR Part 211, not 111....
Posted by Steve Baugh
30 May 2012 | 21h36